These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 9892793

  • 21. Effect of nitrates on LOS pressure in achalasia: a potential therapeutic aid.
    Gelfond M, Rozen P, Keren S, Gilat T.
    Gut; 1981 Apr; 22(4):312-8. PubMed ID: 7239323
    [Abstract] [Full Text] [Related]

  • 22. Effect of peroral endoscopic myotomy on esophagogastric junction physiology in patients with achalasia.
    Verlaan T, Rohof WO, Bredenoord AJ, Eberl S, Rösch T, Fockens P.
    Gastrointest Endosc; 2013 Jul; 78(1):39-44. PubMed ID: 23453184
    [Abstract] [Full Text] [Related]

  • 23. Achalasia in central Israel, 1973-83: clinical aspects.
    Arber N, Grossman A, Tiomny E, Rattan J, Kadish U, Novis B, Neuman G, Lilos P, Rozen P, Gilat T.
    Isr J Med Sci; 1994 Dec; 30(12):880-5. PubMed ID: 8002268
    [Abstract] [Full Text] [Related]

  • 24. Achalasia.
    Reynolds JC, Parkman HP.
    Gastroenterol Clin North Am; 1989 Jun; 18(2):223-55. PubMed ID: 2668168
    [Abstract] [Full Text] [Related]

  • 25. Upper esophageal sphincter abnormalities: frequent finding on high-resolution esophageal manometry and associated with poorer treatment response in achalasia.
    Chavez YH, Ciarleglio MM, Clarke JO, Nandwani M, Stein E, Roland BC.
    J Clin Gastroenterol; 2015 Jan; 49(1):17-23. PubMed ID: 24859712
    [Abstract] [Full Text] [Related]

  • 26. Prospective clinical and manometric study comparing pneumatic dilatation and sublingual nifedipine in the treatment of oesophageal achalasia.
    Wallin L, Boesby S.
    Gut; 1992 Feb; 33(2):288. PubMed ID: 1541428
    [No Abstract] [Full Text] [Related]

  • 27. Primary esophageal motor disorders: clinical response to nifedipine.
    Nasrallah SM, Tommaso CL, Singleton RT, Backhaus EA.
    South Med J; 1985 Mar; 78(3):312-5. PubMed ID: 3975747
    [Abstract] [Full Text] [Related]

  • 28. Use of botulinum toxin as a diagnostic/therapeutic trial to help clarify an indication for definitive therapy in patients with achalasia.
    Katzka DA, Castell DO.
    Am J Gastroenterol; 1999 Mar; 94(3):637-42. PubMed ID: 10086644
    [Abstract] [Full Text] [Related]

  • 29. The use of nifedipine for the treatment of achalasia in children.
    Maksimak M, Perlmutter DH, Winter HS.
    J Pediatr Gastroenterol Nutr; 1986 Mar; 5(6):883-6. PubMed ID: 3794905
    [Abstract] [Full Text] [Related]

  • 30. Treatment choices and outcomes of patients with manometrically diagnosed achalasia.
    Yeung JC, Finley C, Hanna WC, Miller L, Ferri L, Urbach DR, Darling GE.
    Dis Esophagus; 2016 Jul; 29(5):472-8. PubMed ID: 25809620
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Combined treatment of achalasia - botulinum toxin injection followed by pneumatic dilatation: long-term results.
    Kroupa R, Hep A, Dolina J, Valek V, Matyasova Z, Prokesova J, Mrazova J, Sedmik J, Novotny I.
    Dis Esophagus; 2010 Feb; 23(2):100-5. PubMed ID: 19732128
    [Abstract] [Full Text] [Related]

  • 33. Achalasia: diagnosis, management, and clinical course in 16 children.
    Berquist WE, Byrne WJ, Ament ME, Fonkalsrud EW, Euler AR.
    Pediatrics; 1983 May; 71(5):798-805. PubMed ID: 6835765
    [Abstract] [Full Text] [Related]

  • 34. Non-surgical treatment of achalasia.
    Tack J, Janssens J, Vantrappen G.
    Hepatogastroenterology; 1991 Dec; 38(6):493-7. PubMed ID: 1778576
    [Abstract] [Full Text] [Related]

  • 35. Outcomes of treatment for achalasia depend on manometric subtype.
    Rohof WO, Salvador R, Annese V, Bruley des Varannes S, Chaussade S, Costantini M, Elizalde JI, Gaudric M, Smout AJ, Tack J, Busch OR, Zaninotto G, Boeckxstaens GE.
    Gastroenterology; 2013 Apr; 144(4):718-25; quiz e13-4. PubMed ID: 23277105
    [Abstract] [Full Text] [Related]

  • 36. Balloon dilation of the esophago-gastric junction affects lower and upper esophageal sphincter function in achalasia.
    Wauters L, Van Oudenhove L, Selleslagh M, Vanuytsel T, Boeckxstaens G, Tack J, Omari T, Rommel N.
    Neurogastroenterol Motil; 2014 Jan; 26(1):69-76. PubMed ID: 24004089
    [Abstract] [Full Text] [Related]

  • 37. Esophageal motility disorder achalasia.
    Richter JE.
    Curr Opin Otolaryngol Head Neck Surg; 2013 Dec; 21(6):535-42. PubMed ID: 24136218
    [Abstract] [Full Text] [Related]

  • 38. Multiple good options are available for achalasia management.
    Clayton SB, Castell DO.
    J Clin Gastroenterol; 2015 Mar; 49(3):194-8. PubMed ID: 24618506
    [Abstract] [Full Text] [Related]

  • 39. Non-surgical management of achalasia.
    Bourgeois N, Coffernils M, Sznajer Y, Panzer JM, Gelin M, Cremer M.
    Acta Gastroenterol Belg; 1992 Mar; 55(3):260-3. PubMed ID: 1632143
    [Abstract] [Full Text] [Related]

  • 40. Treatment of achalasia: botulinum toxin injection vs. pneumatic balloon dilation. A prospective study with long-term follow-Up.
    Allescher HD, Storr M, Seige M, Gonzales-Donoso R, Ott R, Born P, Frimberger E, Weigert N, Stier A, Kurjak M, Rösch T, Classen M.
    Endoscopy; 2001 Dec; 33(12):1007-17. PubMed ID: 11740642
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.